Our longitudinal data additionally reveal that individual RFC1 disease progression can include sudden phases of rapid, MSA-C–like ataxia progression up to 5.5 SARA points per year and that such phases of accelerated progression can occur after variable disease duration (5–15 years). This evidence concerns the gene RFC1 and cerebellar ataxia.